Group 1 - The core point of the news is that Bibet has experienced a significant decline in its stock price, dropping 5.01% on February 2, with a total market value of 18.249 billion yuan and a cumulative decline of 22.17% over four consecutive days [1] - Bibet is a pharmaceutical company based in Guangzhou, established on January 19, 2012, and focuses on the independent research and development of innovative drugs [1] - The stock trading volume on February 2 was 62.963 million yuan, with a turnover rate of 3.27% [1] Group 2 - From the perspective of major fund holdings, one fund under China Merchants Fund has a significant position in Bibet, with the China Merchants CSI Robot ETF holding 2,789 shares, accounting for 0.0051% of the circulating shares [2] - The fund has incurred a floating loss of approximately 5,968.46 yuan today, with a total floating loss of 33,900 yuan during the four-day decline [2] - The China Merchants CSI Robot ETF was established on January 19, 2024, with a current scale of 309 million yuan and a year-to-date return of 4.39% [2]
必贝特股价跌5.01%，招商基金旗下1只基金重仓，持有2789股浮亏损失5968.46元